TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

KEY THERAP

RespiratoryDermatologyOncology
Generics

KEY THERAP is a generic drug manufacturer focused on Respiratory, Dermatology, Oncology. Key products include ZONTIVITY.

1983
Since
4
Drugs
-
Trials
37
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

BUTALBITAL, ACETAMINOPHEN AND CAFFEINE 2025-08-04
Labeling
DEXAMETHASONE 2024-09-17
DEXAMETHASONE 2024-07-01
Labeling
DEXAMETHASONE 2024-06-25
Labeling
DEXAMETHASONE 2024-06-24
Labeling
DEXAMETHASONE 2024-06-07
Labeling
DEXAMETHASONE 2024-06-05
Labeling
DEXAMETHASONE 2024-06-05
Labeling
DEXAMETHASONE 2024-06-05
Labeling
DEXAMETHASONE 2024-06-05
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Respiratory 43%
1 drugs
Dermatology 43%
1 drugs
Oncology 7%
0 drugs Phase 1: 1
Gastroenterology 7%
0 drugs Phase 1: 1

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Oncology, Dermatology, Gastroenterology
APOTHECON specialty
Dermatology, Gastroenterology, Respiratory
EXTROVIS big-pharma
Oncology, Dermatology, Respiratory, Gastroenterology
Gilead Sciences biotech
Oncology, Gastroenterology, Respiratory
Novartis big-pharma
Oncology, Respiratory